{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T06:02:43Z","timestamp":1782194563815,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.ijpharm.2006.07.054","type":"journal-article","created":{"date-parts":[[2006,8,17]],"date-time":"2006-08-17T16:51:39Z","timestamp":1155833499000},"page":"81-88","source":"Crossref","is-referenced-by-count":48,"title":["Design of a transdermal delivery system for aspirin as an antithrombotic drug"],"prefix":"10.1016","volume":"327","author":[{"given":"H.O.","family":"Ammar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ghorab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"El-Nahhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2006.07.054_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2174\/156720106777731037","article-title":"A transdermal delivery system for glipizide","volume":"3","author":"Ammar","year":"2006","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib2","first-page":"71","article-title":"Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients","volume":"328","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.ijpharm.2006.07.054_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0928-0987(98)00010-4","article-title":"Influence of propylene glycol and isopropyl myristate on the in vitro percutaneous penetration of diclofenac sodium from carbopol gels","volume":"7","author":"Arellano","year":"1999","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0378-5173(94)00267-9","article-title":"Influence of propylene glycol as cosolvent on mechanisms of drug transport from hydrogels","volume":"116","author":"Bendas","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib5","unstructured":"Block, L.H., 1995. Medicated applications. In: Gennaro, A.R. (Ed.), Remington, pp. 1577\u20131591."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0160-5402(80)90024-8","article-title":"The electronic aggregometer: a novel device for assessing platelet behaviour in blood","volume":"3","author":"Cardinal","year":"1980","journal-title":"J. Pharmacol. Methods"},{"key":"10.1016\/j.ijpharm.2006.07.054_bib7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1472-8206.2003.00137.x","article-title":"Differences in the effects of extended-release aspirin and plain-formulated aspirin on prostanoids and nitric oxide in healthy volunteers","volume":"17","author":"De La Cruz","year":"2003","journal-title":"Fund. Clin. Pharm."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib8","first-page":"167","article-title":"Effect of nifedipine and aspirin on platelet aggregation: a study in hypertensive patients and normal volunteers","volume":"27","author":"Desai","year":"1995","journal-title":"Ind. J. Pharm."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib9","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/jps.2600681024","article-title":"Dissolution behavior of commercial enteric-coated aspirin tablets","volume":"68","author":"Embil","year":"1979","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2004.03.012","article-title":"Entrapment and release of quinoline derivatives using a hydrogel of a low molecular weight gelator","volume":"97","author":"Friggeri","year":"2004","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/01.CIR.88.2.556","article-title":"Transdermal modification of platelet function: a dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis","volume":"88","author":"Keimowitz","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ijpharm.2006.07.054_bib12","first-page":"3002","article-title":"Transdermal aspirin and gastric ulcer healing after coronary artery stent placement","volume":"94","author":"Keimowitz","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ijpharm.2006.07.054_bib13","first-page":"200","article-title":"Transdermal aspirin: influence of platelet aggregation and lipid peroxides","volume":"63","author":"Krishna","year":"2000","journal-title":"Ind. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib14","series-title":"Practical Hematology","first-page":"339","article-title":"Investigation of homeostasis","author":"Laffan","year":"2001"},{"key":"10.1016\/j.ijpharm.2006.07.054_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1365-4362.1998.00369.x","article-title":"Cyclodextrins: new drug delivery systems in dermatology","volume":"37","author":"Loftsson","year":"1998","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib16","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nsb0895-637","article-title":"The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase","volume":"2","author":"Loll","year":"1995","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1445-5994.2003.00360.x","article-title":"Effect of different aspirin doses on platelet aggregation in patients with stable coronary artery disease","volume":"33","author":"Malhotra","year":"2003","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib18","unstructured":"Mizobuchi, N., Hasegawa, Y., Kawada, M., Hisaichi, S., 2001. Stable aspirin-containing preparations for external use. US Patent 6,268,355."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib19","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1248\/bpb.25.134","article-title":"In vitro skin permeation of morphine hydrochloride during the finite application of penetration-enhancing system containing water, ethanol and l-menthol","volume":"25","author":"Morimoto","year":"2002","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib20","doi-asserted-by":"crossref","first-page":"470S","DOI":"10.1378\/chest.114.5_Supplement.470S","article-title":"Platelet-active drugs: the relationships among dose, effectiveness and side-effects","volume":"114","author":"Patrono","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.ijpharm.2006.07.054_bib21","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJM199405053301808","article-title":"Aspirin as an antiplatelet drug","volume":"330","author":"Patrono","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib22","doi-asserted-by":"crossref","first-page":"62S","DOI":"10.1016\/S0002-9343(00)00645-8","article-title":"Aspirin: new cardiovascular uses for an old drug","volume":"110","author":"Patrono","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib23","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJM198411083111902","article-title":"Dose-related kinetics of aspirin: presystemic acetylation of platelet cyclooxygenase","volume":"311","author":"Pedersen","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib24","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1023\/A:1015832903398","article-title":"Mechanism of ethanol-enhanced estradiol permeation across human skin in vivo","volume":"7","author":"Pershing","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib25","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1073\/pnas.72.8.3073","article-title":"Acetylation of prostaglandin synthase by aspirin","volume":"72","author":"Roth","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00003495-199550010-00002","article-title":"Antiplatelets drugs. A comparative review","volume":"50","author":"Schror","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.ijpharm.2006.07.054_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2340\/000155557015","article-title":"The transient and cumulative effect of sodium lauryl sulphate on the epidermal barrier assessed by transepidermal water loss: inter-individual variation","volume":"70","author":"Tupker","year":"1990","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib28","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJM199110313251801","article-title":"A comparaison of two doses of aspirin in patients after a transient ischemic attack or minor ischemic stroke","volume":"325","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.2042-7158.1997.tb06813.x","article-title":"Caracterization of the influence of some cyclodextrins on the stratum corneum from the hairless mouse","volume":"49","author":"Victoria","year":"1997","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib30","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJM198304073081402","volume":"308","author":"Weksler","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpharm.2006.07.054_bib31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.addr.2003.10.025","article-title":"Penetration enhancers","volume":"56","author":"Williams","year":"2004","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517306006089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517306006089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T01:05:15Z","timestamp":1707181515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517306006089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0378517306006089"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2006.07.054","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}